Medline ® Abstract for Reference 40
of 'Infectious complications of intravesical BCG immunotherapy'
40
TI
Tuberculous spondylitis as a complication of intravesical bacillus Calmette-Guerin therapy.
AU
Fishman JR, Walton DT, Flynn NM, Benson DR, deVere White RW
SO
J Urol. 1993;149(3):584.
We report a case of tuberculous spondylitis following intravesical bacillus Calmette-Guerin (BCG) instillation. A 90-year-old male physician living in South Africa received an uncomplicated 6-week course of intravesical BCG (Japanese 172 strain) for high grade superficial bladder carcinoma. He experienced a sudden onset of debilitating lower back pain 16 months following this treatment. A lytic lesion involving the anterior T11 and T12 vertebral bodies was diagnosed and subsequently biopsied. An acid-fast organism was isolated after 3 weeks of incubation and was confirmed through deoxyribonucleic acid probe hybridization as a mycobacterium. High performance liquid chromatography analysis speciated the organism as Mycobacterium bovis BCG, proving that it was acquired through the intravesical therapy.
AD
Department of Urology, University of California, School of Medicine, Davis, Sacramento.
PMID
